Understanding PBM Math: Disparities in Blood Pressure Prescription Revenue

Sunday, 27 October 2024, 11:02

PBM Math reveals stark differences in revenue for blood pressure prescriptions, with big chains earning $23.55 while small drugstores receive only $1.51. This disparity highlights the significant role of pharmacy benefit managers (PBMs) in the pharmaceutical landscape. Dr. Alexander Oshmyansky, a co-founder of the Mark Cuban Cost Plus Drug Company, emphasizes that PBMs take a substantial cut of the $400 billion spent on pharmaceuticals annually.
Medpagetoday
Understanding PBM Math: Disparities in Blood Pressure Prescription Revenue

Implications of PBM Math on Pharmacy Revenue

In recent discussions surrounding pharmacy benefit managers (PBMs), alarming figures have surfaced showcasing their impact on revenue generated from blood pressure prescriptions.

Examining Revenue Trends

  • Big chain pharmacies receive approximately $23.55 for each blood pressure medication.
  • Conversely, small drugstores earn only $1.51 for the same prescriptions.

Dr. Alexander Oshmyansky pointed out that this situation exemplifies how PBMs siphon off a staggering portion of the pharmaceutical budget.

Impact of PBM Practices on Healthcare

The implications of these financial practices are profound, affecting both pharmacy sustainability and patient access to medications.

Call to Action

  1. Support local pharmacies facing challenges due to PBM practices.
  2. Advocate for transparency in pharmaceutical pricing.
  3. Educate other healthcare stakeholders about the risks of PBM control.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe